Search
BIO 2026: Rakuten Medical's drug-device 'photoimmunotherapy' is already approved in Japan for head & neck cancer - it is currently in a global phase 3 with an eye on a U.S. approval
COO Abhijit Bhatia describes how it works, and walks us through the design of the phase 3 and Rakuten Medical's global ambitions. Coverage brought to you by
1 day ago
.png){kind=logo}